mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse activating transcription factor 2 genomic DNA homoはlethal ATF2 (CRE-BP1) is a transcription factor of the ATF/CREB family. This protein has a zinc finger structure as a transactivation domain located at the amino terminus and a leucin zipper motif, and phosphorylated by the stress-activated protein kinase such as the Jun amino-terminal kinase and p38. ATF2 deficient mice die shortly after birth and display symptoms of severe respiratory distress with lungs filled with meconium. This strain is useful as an animal model for meconium aspiration syndrome (MAS). 開発年:1999年 開発者:前川利男先生 機関名:理化学研究所 分子遺伝学研究室 B6 94%, CBA 6% 10代以上 Shunsuke ISHII C(3〜6か月) Backcross to C57BL/6 (Heterozygote x C57BL/6JJcl) ATF2o Knock out (CRE-BP1)-B6 ATF2o Knock out (CRE-BP1)-B6 RIKEN In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Biol. Chem., 274, 17813-17819 (1999).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. <a href='https://brc.riken.jp/mus/pcr01046'>Genotyping protocol -PCR-</a> TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] Cell Biology Research RBRC01046 true 石井 俊輔 Developed by Drs. Toshio Maekawa and Shunsuke Ishii, RIKEN Tsukuba Institute in 1999. 独立行政法人理化学研究所 Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="http://rtcweb.rtc.riken.jp/lab/mg/en/mg.html" target="_blank">Lab HP</A> 良好 homoはlethal C (3-6 months) 良好homoはlethal 条件を付加する。<br>研究成果の公表にあたって譲渡者の指定する文献を引用する。J. Biol. Chem., 274, 17813-17819 (1999).<br>研究成果の公表にあたって謝辞の表明を必要とする。 開発年:1999年開発者:前川利男先生機関名:理化学研究所 分子遺伝学研究室B6 94%, CBA 6% 10代以上 B6.Cg-Atf2<tm1Sis>/Rbrc B6.Cg-Atf2<tm1Sis>/Rbrc